IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Therapeutic Advances in Respiratory Disease- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

4.74

h-Index

 41

Rank

 2985

SJR

 1.219

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Therapeutic Advances in Respiratory Disease
Abbreviation Ther. Adv. Respir. Dis.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)
h-index 41
Overall Rank/Ranking 2985
SCImago Journal Rank (SJR) 1.219
Impact Score 4.74
Publisher SAGE Publications Ltd
Country United Kingdom
ISSN 17534658, 17534666




About Therapeutic Advances in Respiratory Disease


Therapeutic Advances in Respiratory Disease is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1). It is published by SAGE Publications Ltd. The overall rank of Therapeutic Advances in Respiratory Disease is 2985. According to SCImago Journal Rank (SJR), this journal is ranked 1.219. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 41. The best quartile for this journal is Q1.

The ISSN of Therapeutic Advances in Respiratory Disease journal is 17534658, 17534666. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Respiratory Disease is cited by a total of 994 articles during the last 3 years (Preceding 2021).


Therapeutic Advances in Respiratory Disease Impact Score 2021-2022


The impact score (IS) 2021 of Therapeutic Advances in Respiratory Disease is 4.74, which is computed in 2022 as per its definition. Therapeutic Advances in Respiratory Disease IS is increased by a factor of 0.83 and approximate percentage change is 21.23% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Therapeutic Advances in Respiratory Disease Impact Score 2022 Prediction


IS 2021 of Therapeutic Advances in Respiratory Disease is 4.74. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Therapeutic Advances in Respiratory Disease. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 4.74
2020 3.91
2019 3.09
2018 3.24
2017 3.69
2016 2.96
2015 2.36
2014 2.42

Therapeutic Advances in Respiratory Disease h-index


  Table Setting

Therapeutic Advances in Respiratory Disease has an h-index of 41. It means 41 articles of this journal have more than 41 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Therapeutic Advances in Respiratory Disease ISSN


The ISSN of Therapeutic Advances in Respiratory Disease is 17534658, 17534666. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Therapeutic Advances in Respiratory Disease Rank and SCImago Journal Rank (SJR)


The overall rank of Therapeutic Advances in Respiratory Disease is 2985. According to SCImago Journal Rank (SJR), this journal is ranked 1.219. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Therapeutic Advances in Respiratory Disease Publisher


Table Setting

Therapeutic Advances in Respiratory Disease is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2007-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Therapeutic Advances in Respiratory Disease is Ther. Adv. Respir. Dis.. This abbreviation ('Ther. Adv. Respir. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Therapeutic Advances in Respiratory Disease


If your research field is/are related to Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Archivos de Neurociencias journal 24106 Instituto Nacional de Neurologia y Neurocirugia Manuel Velosco Suarez 5 0.03
Cytotechnology journal 11188 Springer Netherlands 65 2.12
npj Systems Biology and Applications journal 2393 Nature Publishing Group 25 3.97
Critical Military Studies journal 11663 Taylor and Francis Ltd. 17 0.90
Current Pharmaceutical Analysis journal 19669 Bentham Science Publishers B.V. 25 0.59
Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses journal 21154 Jannetti Publications, Inc. 33 0.34
Revue du Podologue journal 23169 Elsevier Masson s.r.l. 2 0.03
Archives journal 23990 British Records Association 2 0.21
Pacific Accounting Review journal 12137 Emerald Group Publishing Ltd. 24 2.16
Giant journal 1572 Elsevier Ltd. 9 5.57

Check complete list




Year wise Impact Score (IS) of Therapeutic Advances in Respiratory Disease

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 4.74
2020 3.91
2019 3.09
2018 3.24
2017 3.69
2016 2.96
2015 2.36
2014 2.42



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All

Top Journals/Conferences in Pulmonary and Respiratory Medicine

Lancet Respiratory Medicine,The
Elsevier Ltd. | United Kingdom

American Journal of Respiratory and Critical Care Medicine
American Thoracic Society | United States

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

European Respiratory Journal
European Respiratory Society | Switzerland

Journal of Heart and Lung Transplantation
Elsevier USA | United States

Thorax
BMJ Publishing Group | United Kingdom

Chest
American College of Chest Physicians | United States

European Respiratory Review
European Respiratory Society | Switzerland

American Journal of Respiratory Cell and Molecular Biology
American Thoracic Society | United States

See All